A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted). Shingrix is indicated for the preven ...

Despite its name, bitter melon’s benefits may be surprisingly sweet. Also called bitter gourd, this bumpy green vegetable has ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

Introduction: Herpes zoster is the reactivation of the varicella zoster virus (VZV), which remained quiescent in the Gasser ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...